https://orcid.org/0000-0002-7450-4434
Citations (129)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Shu-xian Xu, Xin-hui Xie, Lihua Yao, Li-chang Chen, Qirong Wan, Zhen-hua Chen & Zhongchun Liu. (2023) Trajectories of Efficacy and Cognitive Function During Electroconvulsive Therapy Course in Young Adults with Treatment-Resistant Depression. Neuropsychiatric Disease and Treatment 19, pages 267-281.
Read now
Read now
Evelyn Walter, Matthäus Traunfellner, Martin Gleitsmann, Michaela Zalesak & Christian Helmenstein. (2023) The cost-of-illness and burden-of-disease of treatment-resistant depression in Austria. Journal of Medical Economics 26:1, pages 1432-1444.
Read now
Read now
Massimiliano Buoli, Francesca Legnani, Guido Nosari, Anna Pan, Valentina Ciappolino, Cecilia Maria Esposito, Alessandro Ceresa, Martina Di Paolo, Teresa Surace, Anna Maria Auxilia, Martina Capellazzi, Ilaria Tagliabue, Luisa Cirella, Francesco Zanelli Quarantini, Antonios Dakanalis, Massimo Clerici, Enrico Capuzzi & Alice Caldiroli. (2023) Which clinical factors and biochemical parameters are associated with late-life major depression?. International Journal of Psychiatry in Clinical Practice 27:4, pages 359-366.
Read now
Read now
Raul Escamilla, María Eva González-Trujano, Jesús M. González Mariscal, Jesús Martín Torres-Valencia, Héctor Guzmán-González, José Luis Vega & Anja Loizaga-Velder. (2023) A Proposal to Study the Safety and Efficacy of Psilocybe cubensis in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder. Journal of Psychoactive Drugs 55:5, pages 570-580.
Read now
Read now
Fabio Panariello, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Diana De Ronchi, Alessandro Serretti & Chiara Fabbri. (2023) Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting. The World Journal of Biological Psychiatry 24:5, pages 439-448.
Read now
Read now
Phern Chern Tor, Nurmiati Amir, Johnson Fam, Roger Ho, Pichai Ittasakul, Margarita M Maramis, Benita Ponio, Dharmawan Ardi Purnama, Wanida Rattanasumawong, Elizabeth Rondain, Ahmad Hatim Bin Sulaiman, Kannokarn Wiroteurairuang & Kok Yoon Chee. (2022) A Southeast Asia Consensus on the Definition and Management of Treatment-Resistant Depression. Neuropsychiatric Disease and Treatment 18, pages 2747-2757.
Read now
Read now
Tobore Onojighofia Tobore. (2022) On stimulus persistence and human behavior: the stimulus persistence unification theory. Communicative & Integrative Biology 15:1, pages 240-252.
Read now
Read now
Xun Zhang, Yan-Mei Guo, Yu-Ping Ning, Li-Ping Cao, Ying-Hua Rao, Jia-Qi Sun, Ming-Jun Qing & Wei Zheng. (2022) Adjunctive vagus nerve stimulation for treatment-resistant depression: a preliminary study. International Journal of Psychiatry in Clinical Practice 26:4, pages 337-342.
Read now
Read now
Alessandro Gialluisi, Federica Santonastaso, Marialaura Bonaccio, Francesca Bracone, Nitin Shivappa, James R Hebert, Chiara Cerletti, Maria Benedetta Donati, Giovanni de Gaetano & Licia Iacoviello. (2021) Circulating Inflammation Markers Partly Explain the Link Between the Dietary Inflammatory Index and Depressive Symptoms. Journal of Inflammation Research 14, pages 4955-4968.
Read now
Read now
Drishti Shah, Wanhong Zheng, Lindsay Allen, Wenhui Wei, Traci LeMasters, Suresh Madhavan & Usha Sambamoorthi. (2021) Using a machine learning approach to investigate factors associated with treatment-resistant depression among adults with chronic non-cancer pain conditions and major depressive disorder. Current Medical Research and Opinion 37:5, pages 847-859.
Read now
Read now
Dominic Pilon, Swapna Karkare, Maryia Zhdanava, John J. Sheehan, Aurélie Côté-Sergent, Aditi Shah, Oliver J. Lopena, Patrick Lefebvre, Kruti Joshi & Leslie Citrome. (2021) Health care resource use, short-term disability days, and costs associated with states of persistence on antidepressant lines of therapy. Journal of Medical Economics 24:1, pages 1299-1308.
Read now
Read now
Articles from other publishers (118)
Matthias Stangl, Sabrina L. Maoz & Nanthia Suthana. (2023) Mobile cognition: imaging the human brain in the ‘real world’. Nature Reviews Neuroscience 24:6, pages 347-362.
Crossref
Crossref
Debora de A. Simoes Moreira, Luís Eduardo Gauer, Guilherme Teixeira, Amanda Carolina Fonseca da Silva, Stefanie Cavalcanti & João Quevedo. (2023) Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis. Journal of Affective Disorders 330, pages 227-238.
Crossref
Crossref
D. S. Petelin, V. E. Bezrukov, R. M. Shishorin & B. A. Volel. (2023) Comparison of the Effectiveness of Transcranial Magnetic Stimulation Protocols as an Adjunct to the Pharmacotherapy of Refractory Depression with Comorbid Chronic Pain. Neuroscience and Behavioral Physiology.
Crossref
Crossref
Philip Borsellino, Reese I. Krider, Deanna Chea, Ryan Grinnell & Thomas A. Vida. (2023) Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression. Pharmaceuticals 16:5, pages 742.
Crossref
Crossref
Carol Jamieson, Vanina Popova, Ella Daly, Kimberly Cooper, Wayne C. Drevets, Heather M. Rozjabek & Jaskaran Singh. (2023) Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant. Health and Quality of Life Outcomes 21:1.
Crossref
Crossref
Natalie B. Riblet, Yinong Young-Xu, Brian Shiner, Paula P. Schnurr & Bradley V. Watts. (2023) The efficacy and safety of buprenorphine for the treatment of depression: A systematic review and meta-analysis. Journal of Psychiatric Research 161, pages 393-401.
Crossref
Crossref
Wole Akosile, Babangida Tiyatiye, David Colquhoun & Ross Young. (2023) Management of depression in patients with coronary artery disease: A systematic review. Asian Journal of Psychiatry 83, pages 103534.
Crossref
Crossref
Antonio Tundo, Sophia Betro’, Rocco de Filippis, Fulvia Marchetti, Daniele Nacca, Roberta Necci & Marica Iommi. (2023) Pramipexole Augmentation for Treatment-Resistant Unipolar and Bipolar Depression in the Real World: A Systematic Review and Meta-Analysis. Life 13:4, pages 1043.
Crossref
Crossref
Monika Marcinkowska, Barbara Mordyl, Agata Siwek, Monika Głuch-Lutwin, Tadeusz Karcz, Alicja Gawalska, Michał Sapa, Adam Bucki, Katarzyna Szafrańska, Bartosz Pomierny, Karolina Pytka, Magdalena Kotańska, Kamil Mika & Marcin Kolaczkowski. (2023)
Dual Molecules Targeting 5-HT
6
and GABA-A Receptors as a New Approach to Combat Depression Associated with Neuroinflammation
. ACS Chemical Neuroscience.
Crossref
Crossref
Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James C. Bennett, Megan Croal, Charles DeBattista, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Muhammad Ishrat Husain, John R. Kelly, Molly R. Lennard-Jones, Rasmus W. Licht, Lindsey Marwood, Sunil Mistry, Tomáš Páleníček, Ozlem Redjep, Dimitris Repantis, Robert A. Schoevers, Batya Septimus, Hollie J. Simmons, Jair C. Soares, Metten Somers, Susan C. Stansfield, Jessica R. Stuart, Hannah H. Tadley, Nisha K. Thiara, Joyce Tsai, Mourad Wahba, Sam Williams, Rachel I. Winzer, Allan H. Young, Matthew B. Young, Sid Zisook & Ekaterina Malievskaia. (2023) Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life. Journal of Affective Disorders 327, pages 120-127.
Crossref
Crossref
Rebecca Strafella, Davide Momi, Reza Zomorrodi, Jennifer Lissemore, Yoshihiro Noda, Robert Chen, Tarek K. Rajji, John D. Griffiths, Fidel Vila-Rodriguez, Jonathan Downar, Zafiris J. Daskalakis, Daniel M. Blumberger & Daphne Voineskos. (2023) Identifying Neurophysiological Markers of Intermittent Theta-Burst Stimulation in Treatment-Resistant Depression using Transcranial Magnetic Stimulation- Electroencephalography. Biological Psychiatry.
Crossref
Crossref
C. Lybbert, J. Huang, K. G. Jones, B. J. Mickey, S. Tadler, D. Odell, J. Stanford & K. Kuck. (2023) Clinical validation of an adapted Eleveld Model for high-dose propofol treatments for depression. Journal of Clinical Monitoring and Computing.
Crossref
Crossref
Wei Zheng, Dong-Bin Cai, Sha Nie, Jian-Hua Chen, Xing-Bing Huang, Stephan Goerigk, Andre Russowsky Brunoni & Wei Zheng. (2023) Adjunctive transcranial alternating current stimulation for patients with major depressive disorder: A systematic review and meta-analysis. Frontiers in Psychiatry 14.
Crossref
Crossref
Anna Maria Gutowska-Ibbs, Agnieszka Permoda-Pachuta & Hanna Karakuła- Juchnowicz. (2023) An analysis of the fulfilment criteria for a medical experiment with regards to the use of intravenous ketamine in the treatment of drugresistant depression. Current Problems of Psychiatry 24, pages 76-86.
Crossref
Crossref
Octavian Vasiliu. (2023) Efficacy, Tolerability, and Safety of Toludesvenlafaxine for the Treatment of Major Depressive Disorder—A Narrative Review. Pharmaceuticals 16:3, pages 411.
Crossref
Crossref
Jan Lazur, Kamil Hnatyk, Katarzyna Kała, Katarzyna Sułkowska-Ziaja & Bożena Muszyńska. (2023) Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review. Antioxidants 12:3, pages 623.
Crossref
Crossref
Laura A. Hannah, Cathy M. Walsh, Louise Jopling, Jesus Perez, Rudolf N. Cardinal & Rory A. Cameron. (2023) Economic evaluation of interventions for treatment-resistant depression: A systematic review. Frontiers in Psychiatry 14.
Crossref
Crossref
Franciele Cordeiro Gabriel, Airton Tetelbom Stein, Daniela de Oliveira Melo, Gessica Caroline Henrique Fontes-Mota, Itamires Benício dos Santos, Camila da Silva Rodrigues, Andrea Dourado, Mônica Cristiane Rodrigues, Renério Fráguas, Ivan D. Florez, Diogo Telles Correia & Eliane Ribeiro. (2023) Guidelines’ recommendations for the treatment-resistant depression: A systematic review of their quality. PLOS ONE 18:2, pages e0281501.
Crossref
Crossref
Agata Zięba, Dariusz Matosiuk & Agnieszka A. Kaczor. (2023) The Role of Genetics in the Development and Pharmacotherapy of Depression and Its Impact on Drug Discovery. International Journal of Molecular Sciences 24:3, pages 2946.
Crossref
Crossref
Szilvia Vas, Rege S. Papp, Katalin Könczöl, Emese Bogáthy, Noémi Papp, Csaba Ádori, Máté Durst, Klaudia Sípos, Klementina Ocskay, Imre Farkas, Flóra Bálint, Szilamér Ferenci, Bibiána Török, Anita Kovács, Evelin Szabó, Dóra Zelena, Krisztina J. Kovács, Anna Földes, Erzsébet Kató, László Köles, György Bagdy, Miklós Palkovits & Zsuzsanna E. Tóth. (2023) Prolactin-Releasing Peptide Contributes to Stress-Related Mood Disorders and Inhibits Sleep/Mood Regulatory Melanin-Concentrating Hormone Neurons in Rats. The Journal of Neuroscience 43:5, pages 846-862.
Crossref
Crossref
Raffaella Zanardi, Matteo Carminati, Francesco Attanasio, Chiara Fabbri & Alessandro Serretti. (2023) Genetics of nonpharmacological treatments of depression. Psychiatric Genetics 33:1, pages 1-7.
Crossref
Crossref
Kwonmok Ko, Emma I. Kopra, Anthony J. Cleare & James J. Rucker. (2023) Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis. Journal of Affective Disorders 322, pages 194-204.
Crossref
Crossref
Monika Marcinkowska, Barbara Mordyl, Nikola Fajkis-Zajaczkowska, Agata Siwek, Tadeusz Karcz, Alicja Gawalska, Adam Bucki, Paweł Żmudzki, Anna Partyka, Magdalena Jastrzębska-Więsek, Bartosz Pomierny, Maria Walczak, Magdalena Smolik, Karolina Pytka, Kamil Mika, Magdalena Kotańska & Marcin Kolaczkowski. (2023) Hybrid molecules combining GABA-A and serotonin 5-HT6 receptors activity designed to tackle neuroinflammation associated with depression. European Journal of Medicinal Chemistry 247, pages 115071.
Crossref
Crossref
Anna Winiarska-Mieczan, Małgorzata Kwiecień, Karolina Jachimowicz-Rogowska, Janine Donaldson, Ewa Tomaszewska & Ewa Baranowska-Wójcik. (2023) Anti-Inflammatory, Antioxidant, and Neuroprotective Effects of Polyphenols—Polyphenols as an Element of Diet Therapy in Depressive Disorders. International Journal of Molecular Sciences 24:3, pages 2258.
Crossref
Crossref
Joanna Rymaszewska, Tomasz Wieczorek, Karolina Fila-Witecka, Katarzyna Smarzewska, Artur Weiser, Patryk Piotrowski & Paweł Tabakow. (2023) Various neuromodulation methods including Deep Brain Stimulation of the medial forebrain bundle combined with psychopharmacotherapy of treatment-resistant depression—Case report. Frontiers in Psychiatry 13.
Crossref
Crossref
Sabrina Mörkl, Mary I. Butler & Sonja Lackner. (2023) Advances in the gut microbiome and mood disorders. Current Opinion in Psychiatry 36:1, pages 1-7.
Crossref
Crossref
Aurora Garcia, Aina M. Yáñez, Miquel Bennasar-Veny, Capilla Navarro, Joan Salva, Olga Ibarra, Rocío Gomez-Juanes, María J. Serrano-Ripoll, Bárbara Oliván, Margalida Gili, Miquel Roca, Pau Riera-Serra, Alejandra Aguilar-Latorre, Jesús Montero-Marin & Mauro Garcia-Toro. (2023) Efficacy of an adjuvant non-face-to-face multimodal lifestyle modification program for patients with treatment-resistant major depression: A randomized controlled trial. Psychiatry Research 319, pages 114975.
Crossref
Crossref
Jifei Sun, Linjie Xu, Yue Ma, Chunlei Guo, Zhongming Du, Shanshan Gao, Yi Luo, Qingyan Chen, Yang Hong, Xue Yu, Xue Xiao & Jiliang Fang. (2023) Different characteristics of striatal resting-state functional conectivity in treatment-resistant and non-treatment-resistant depression. Psychiatry Research: Neuroimaging 328, pages 111567.
Crossref
Crossref
Jifei Sun, Yue Ma, Chunlei Guo, Zhongming Du, Limei Chen, Zhi Wang, Xiaojiao Li, Ke Xu, Yi Luo, Yang Hong, Xue Yu, Xue Xiao, Jiliang Fang & Jie Lu. (2023) Distinct patterns of functional brain network integration between treatment-resistant depression and non treatment-resistant depression: A resting-state functional magnetic resonance imaging study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 120, pages 110621.
Crossref
Crossref
Emma Pope, Sabari Muthukrishnan, James Phillips & Sarah Phillips. (2021) A case of treatment-resistant depression in an older adult and a discussion of treatment options. BJPsych Bulletin 46:6, pages 331-336.
Crossref
Crossref
Ray Miller, Sayorn Chin & Ashish Kumar Sedai. (2022) The welfare cost of late-life depression. Journal of Economic Behavior & Organization 204, pages 15-36.
Crossref
Crossref
Nare Amasi-Hartoonian, Carmine Maria Pariante, Annamaria Cattaneo & Luca Sforzini. (2022) Understanding treatment-resistant depression using “omics” techniques: A systematic review. Journal of Affective Disorders 318, pages 423-455.
Crossref
Crossref
Rodolphe H. Lebeau, Indira Mendez-David, Laura Kucynski-Noyau, Céline Henry, David Attali, Marion Plaze, Romain Colle, Emmanuelle Corruble, Alain M. Gardier, Raphaël Gaillard, Jean-Philippe Guilloux & Denis J. David. (2022) Peripheral proteomic changes after electroconvulsive seizures in a rodent model of non-response to chronic fluoxetine. Frontiers in Pharmacology 13.
Crossref
Crossref
Matthew T. Birnie, Alen V. Eapen, Yvonne M. Kershaw, David Lodge, Graham L. Collingridge, Becky L. Conway‐Campbell & Stafford L. Lightman. (2022) Time of day influences stress hormone response to ketamine. Journal of Neuroendocrinology 34:10.
Crossref
Crossref
Ethar Ahmed Mosilhy, Eman E. Alshial, Mennatullah Mohamed Eltaras, Mona Mamdouh Abdel Rahman, Hagar Ismail Helmy, Abdelaziz Habib Elazoul, Omnia Hamdy & Haitham S. Mohammed. (2022) Non-invasive transcranial brain modulation for neurological disorders treatment: A narrative review. Life Sciences 307, pages 120869.
Crossref
Crossref
Sylwia Samojedny, Ewelina Czechowska, Patrycja Pańczyszyn-Trzewik & Magdalena Sowa-Kućma. (2022) Postsynaptic Proteins at Excitatory Synapses in the Brain—Relationship with Depressive Disorders. International Journal of Molecular Sciences 23:19, pages 11423.
Crossref
Crossref
María I. Molina-Echeverry, Roger A. Figueroa-Paz, María M. Cardozo-Rengifo, Valentina Galindo-Velasco & Hernán G. Rincón-Hoyos. (2022) La investigación sobre el tratamiento de depresión con base en registros de historia clínica: análisis de una experiencia en un hospital universitario. Revista Colombiana de Psiquiatría.
Crossref
Crossref
Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, Gabriela Morales-Lima, João Ariel Bonar Fernandes & Renato Filev. (2022) Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research. Addiction Neuroscience 3, pages 100025.
Crossref
Crossref
Rebecca Strafella, Robert Chen, Tarek K. Rajji, Daniel M. Blumberger & Daphne Voineskos. (2022) Resting and TMS-EEG markers of treatment response in major depressive disorder: A systematic review. Frontiers in Human Neuroscience 16.
Crossref
Crossref
AG Poydasheva, IS Bakulin, DO Sinitsyn, AH Zabirova, NA Suponeva, NV Maslenikov, EE Tsukarzi, SN Mosolov & MA Piradov. (2022) Experience of Stanford neuromodulation therapy in patients with treatment-resistant depression. Bulletin of Russian State Medical University:2022(4).
Crossref
Crossref
A. Baldacci, E. Saguin, S. Annette, B. Lahutte, M.-D. Colas & H. Delacour. (2022) Pharmacogénétique des cytochromes appliquée à la prescription des antidépresseurs : mode d’emploi. L'Encéphale 48:4, pages 462-471.
Crossref
Crossref
Jurriaan M. J. L. Brouwer, Arne J. Risselada, Marinka de Wit, Janniek Lubberts, Henrieke Westerhuis, Bennard Doornbos & Hans Mulder. (2022) Lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort study. International Journal of Clinical Pharmacy 44:4, pages 975-984.
Crossref
Crossref
Miguel A. Ortega, Óscar Fraile-Martínez, Cielo García-Montero, Miguel Angel Alvarez-Mon, Guillermo Lahera, Jorge Monserrat, Maria Llavero-Valero, Luis Gutiérrez-Rojas, Rosa Molina, Roberto Rodríguez-Jimenez, Javier Quintero & Melchor Alvarez De Mon. (2022) Biological Role of Nutrients, Food and Dietary Patterns in the Prevention and Clinical Management of Major Depressive Disorder. Nutrients 14:15, pages 3099.
Crossref
Crossref
Kwonmok Ko, Gemma Knight, James J. Rucker & Anthony J. Cleare. (2022) Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review. Frontiers in Psychiatry 13.
Crossref
Crossref
Yanyan Wei, Junhui Feng, Jinbao Ma, Dongning Chen & Jingxu Chen. (2022) Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in patients with affective disorders. Journal of Affective Disorders 309, pages 221-228.
Crossref
Crossref
Markku Lähteenvuo, Heidi Taipale, Antti Tanskanen, Saara Rannanpää & Jari Tiihonen. (2022) Courses of treatment and risk factors for treatment-resistant depression in Finnish primary and special healthcare: A nationwide cohort study. Journal of Affective Disorders 308, pages 236-242.
Crossref
Crossref
Carol Nash. (2022) Enhancing Hopeful Resilience Regarding Depression and Anxiety with a Narrative Method of Ordering Memory Effective in Researchers Experiencing Burnout. Challenges 13:2, pages 28.
Crossref
Crossref
Chaofang Lei, Zhigang Chen, Lili Fan, Zhe Xue, Jianbei Chen, Xihong Wang, Zhen Huang, Yinian Men, Mingzhi Yu, Yueyun Liu & Jiaxu Chen. (2022) Integrating Metabolomics and Network Analysis for Exploring the Mechanism Underlying the Antidepressant Activity of Paeoniflorin in Rats With CUMS-Induced Depression. Frontiers in Pharmacology 13.
Crossref
Crossref
Marco Antonio Caldieraro, Teng Chei Tung, Lina Maria Agudelo Baena, Manuel Vilapriño Duprat, Ricardo Marcelo Corral, Luis Daniel Alviso de la Serna, Erasmo Saucedo, Gabriela Kanevsky & Patricia Cabrera. (2022) Depression and suicidality severity among TRD patients after 1-year under standard of care: Findings from the TRAL study, a multicenter, multinational, observational study in Latin America. Revista de Psiquiatría y Salud Mental.
Crossref
Crossref
Robert Sotille, Herpreet Singh, Anne Weisman & Thomas Vida. (2022) Unraveling the Mysteries of Mental Illness With Psilocybin. Cureus.
Crossref
Crossref
Weigang Pan, Chaomeng Liu, Dandi Zhu, Yi Liu, Peixian Mao, Yanping Ren & Xin Ma. (2022) Prediction of Antidepressant Efficacy by Cognitive Function in First-Episode Late-Life Depression: A Pilot Study. Frontiers in Psychiatry 13.
Crossref
Crossref
Miguel A. Ortega, Óscar Fraile-Martínez, Cielo García-Montero, Miguel Angel Alvarez-Mon, Guillermo Lahera, Jorge Monserrat, Maria Llavero-Valero, Fernando Mora, Roberto Rodríguez-Jiménez, Sonia Fernandez-Rojo, Javier Quintero & Melchor Alvarez De Mon. (2022) Nutrition, Epigenetics, and Major Depressive Disorder: Understanding the Connection. Frontiers in Nutrition 9.
Crossref
Crossref
Shobha Mehta, Jonathan Downar, Benoit H. Mulsant, Daphne Voineskos, Zafiris J. Daskalakis, Cory R. Weissman, Fidel Vila‐Rodriguez & Daniel M. Blumberger. (2022) Effect of high frequency versus theta‐burst repetitive transcranial magnetic stimulation on suicidality in patients with treatment‐resistant depression. Acta Psychiatrica Scandinavica 145:5, pages 529-538.
Crossref
Crossref
Brenda Moreira dos Santos, Gabriele Cheiran Pereira, Elisa Piton, Maria Fernanda Pessano Fialho, Gabriela Becker, Marieli da Silva Carlotto, Luís Fernando Muniz Camargo, Luis Guilherme Ramanzini, Sara Marchesan Oliveira, Gabriela Trevisan, Eliane Maria Zanchet, Micheli Mainardi Pillat & Guilherme Vargas Bochi. (2022) Lower antidepressant response to fluoxetine is associated with anxiety-like behavior, hippocampal oxidative imbalance, and increase on peripheral IL-17 and IFN-γ levels. Behavioural Brain Research 425, pages 113815.
Crossref
Crossref
Fitri Fareez Ramli, Philip J. Cowen & Beata R. Godlewska. (2022) The Potential Use of Ebselen in Treatment-Resistant Depression. Pharmaceuticals 15:4, pages 485.
Crossref
Crossref
Nicolas Upton. (2021) Developing our understanding of nutrition in depression. British Journal of Nutrition 127:7, pages 1010-1017.
Crossref
Crossref
Neyder Contreras, Antistio Alvíz-Amador & Isabella Manzur-Villalobos. (2022) In silico study of dimethyltryptamine analogues against 5-HT1B receptor: Molecular docking, dynamic simulations and ADMET prediction. Journal of Herbmed Pharmacology 11:2, pages 204-212.
Crossref
Crossref
Franciele Cordeiro Gabriel, Airton Tetelbom Stein, Daniela Oliveira de Melo, Géssica Caroline Henrique Fontes-Mota, Itamires Benício dos Santos, Aliandra Fantinell de Oliveira, Renério Fráguas & Eliane Ribeiro. (2022) Quality of clinical practice guidelines for inadequate response to first-line treatment for depression according to AGREE II checklist and comparison of recommendations: a systematic review. BMJ Open 12:4, pages e051918.
Crossref
Crossref
Kristin Evensen, Martin Balslev Jørgensen, Anne Sabers & Klaus Martiny. (2022) Transcutaneous Vagal Nerve Stimulation in Treatment-Resistant Depression: A Feasibility Study. Neuromodulation: Technology at the Neural Interface 25:3, pages 443-449.
Crossref
Crossref
Ellen Scotton, Bárbara Antqueviezc, Mailton França de Vasconcelos, Giovana Dalpiaz, Luiza Paul Géa, Jéferson Ferraz Goularte, Rafael Colombo & Adriane Ribeiro Rosa. (2022) Is (R)-ketamine a potential therapeutic agent for treatment-resistant depression with less detrimental side effects? A review of molecular mechanisms underlying ketamine and its enantiomers. Biochemical Pharmacology 198, pages 114963.
Crossref
Crossref
Yi‐Chun Tsai, Cheng‐Ta Li, Wei‐Kuang Liang, Neil G. Muggleton, Chong‐Chih Tsai, Norden E. Huang & Chi‐Hung Juan. (2021) Critical role of rhythms in prefrontal transcranial magnetic stimulation for depression: A randomized sham‐controlled study. Human Brain Mapping 43:5, pages 1535-1547.
Crossref
Crossref
João M. Bessa, Serafim Carvalho, Inês B. Cunha, Milene Fernandes, Ana Matos-Pires, Rui Neves, Albino J. Oliveira-Maia, Susana Santos & Vítor Santos. (2022) Treatment-Resistant Depression in Portugal: Perspective From Psychiatry Experts. Frontiers in Psychiatry 13.
Crossref
Crossref
Collin J. Amundson, Robert Knight, Georgina M. Ybarra, Jacques Turgeon & Jennifer M. Bingham. (2022) Mitigating the Risk of Adverse Effects Related to Augmentation Therapy for Resistant Major Depressive Disorder: A Case Report. Medicina 58:3, pages 438.
Crossref
Crossref
Momtaz Abdel-Wahab, Tarek Okasha, Mostafa Shaheen, Mohamed Nasr, Tarek Molokheya, Abd ElNasser Omar, Menan A. Rabie, Victor Samy, Hany Hamed & Mohamed Ali. (2022) Clinical Guidelines of the Egyptian Psychiatric Association for the Management of Treatment-Resistant Unipolar Depression in Egypt. Frontiers in Psychiatry 13.
Crossref
Crossref
Yangfeng Xu, Mitchel Kappen, Kathelijne Peremans, Dimitri De Bundel, Ann Van Eeckhaut, Nick Van Laeken, Filip De Vos, Andre Dobbeleir, Jimmy H. Saunders & Chris Baeken. (2022) Accelerated HF-rTMS Modifies SERT Availability in the Subgenual Anterior Cingulate Cortex: A Canine [11C]DASB Study on the Serotonergic System. Journal of Clinical Medicine 11:6, pages 1531.
Crossref
Crossref
Sherry-Anne Muscat, Glenn Hartelius, Courtenay Richards Crouch & Kevin W. Morin. (2022) Optimized Clinical Strategies for Treatment-Resistant Depression: Integrating Ketamine Protocols with Trauma- and Attachment-Informed Psychotherapy. Psych 4:1, pages 119-141.
Crossref
Crossref
Cielo García-Montero, Miguel A. Ortega, Miguel Angel Alvarez-Mon, Oscar Fraile-Martinez, Adoración Romero-Bazán, Guillermo Lahera, José Manuel Montes-Rodríguez, Rosa M. Molina-Ruiz, Fernando Mora, Roberto Rodriguez-Jimenez, Javier Quintero & Melchor Álvarez-Mon. (2022) The Problem of Malnutrition Associated with Major Depressive Disorder from a Sex-Gender Perspective. Nutrients 14:5, pages 1107.
Crossref
Crossref
Éva Borbély, Mária Simon, Eberhard Fuchs, Ove Wiborg, Boldizsár Czéh & Zsuzsanna Helyes. (2022) Novel drug developmental strategies for treatment‐resistant depression. British Journal of Pharmacology 179:6, pages 1146-1186.
Crossref
Crossref
Subha Subramanian, Ruthzaine Lopez, Charles F. Zorumski & Pilar Cristancho. (2022) Electroconvulsive therapy in treatment resistant depression. Journal of the Neurological Sciences 434, pages 120095.
Crossref
Crossref
Yanyan Wei, Junhui Feng, Jinbao Ma, Dongning Chen, Haiting Xu, Lu Yin & Jingxu Chen. (2022) Characteristics of platelet-associated parameters and their predictive values in Chinese patients with affective disorders. BMC Psychiatry 22:1.
Crossref
Crossref
Camila Cosmo, Yosef A. Berlow, Katherine A. Grisanzio, Scott L. Fleming, Abdullah P. Rashed Ahmed, McKenna C. Brennan, Linda L. Carpenter & Noah S. Philip. (2022) Transdiagnostic Symptom Subtypes to Predict Response to Therapeutic Transcranial Magnetic Stimulation in Major Depressive Disorder and Posttraumatic Stress Disorder. Journal of Personalized Medicine 12:2, pages 224.
Crossref
Crossref
Massimiliano Buoli, Enrico Capuzzi, Alice Caldiroli, Alessandro Ceresa, Cecilia Maria Esposito, Cristina Posio, Anna Maria Auxilia, Martina Capellazzi, Ilaria Tagliabue, Teresa Surace, Francesca Legnani, Luisa Cirella, Martina Di Paolo, Guido Nosari, Francesco Zanelli Quarantini, Massimo Clerici, Fabrizia Colmegna & Antonios Dakanalis. (2022) Clinical and Biological Factors Are Associated with Treatment-Resistant Depression. Behavioral Sciences 12:2, pages 34.
Crossref
Crossref
Gerasimos Konstantinou, Jeanette Hui, Abigail Ortiz, Tyler S. Kaster, Jonathan Downar, Daniel M. Blumberger & Zafiris J. Daskalakis. (2021) Repetitive transcranial magnetic stimulation (rTMS) in bipolar disorder: A systematic review. Bipolar Disorders 24:1, pages 10-26.
Crossref
Crossref
Evan R J Goyette, Mark A Cervinski & Jacqueline A Hubbard. (2022) Persistently Positive Urine Amphetamines Confirmation Testing. Clinical Chemistry 68:2, pages 368-369.
Crossref
Crossref
K. Heerlein, S. De Giorgi, G. Degraeve, T. Frodl, W. Hagedoorn, A.J. Oliveira-Maia, C. Otte, V. Perez Sola, S. Rathod, G. Rosso, P. Sierra, A. Vita, J. Morrens, B. Rive, S. Mulhern Haughey, Y. Kambarov & A.H. Young. (2022) Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilization. Journal of Affective Disorders 298, pages 442-450.
Crossref
Crossref
Piotr Gałecki, Jerzy Samochowiec, Magdalena Mikułowska & Agata Szulc. (2022) Treatment-Resistant Depression in Poland—Epidemiology and Treatment. Journal of Clinical Medicine 11:3, pages 480.
Crossref
Crossref
Flurin Cathomas, Laura Bevilacqua, Aarthi Ramakrishnan, Hope Kronman, Sara Costi, Molly Schneider, Kenny L. Chan, Long Li, Eric J. Nestler, Li Shen, Dennis S. Charney, Scott J. Russo & James W. Murrough. (2022) Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depression. Translational Psychiatry 12:1.
Crossref
Crossref
Yoosuk An, Seon Young Park & Ung Gu Kang. (2022) “Drugs of Abuse” as a “New Antidepressant”: - A Review on Pharmacological Mechanisms, Antidepressant Effects, and Abuse Potential. Journal of Korean Neuropsychiatric Association 61:4, pages 243.
Crossref
Crossref
Sophia Walker, Arthur Su & Jayesh Kamath. 2022. Epigenetics of Stress and Stress Disorders. Epigenetics of Stress and Stress Disorders
67
84
.
Elif Tunc-Ozcan, Sarah M. Brooker, Jacqueline A. Bonds, Yung-Hsu Tsai, Radhika Rawat, Tammy L. McGuire, Chian-Yu Peng & John A. Kessler. (2021) Hippocampal BMP signaling as a common pathway for antidepressant action. Cellular and Molecular Life Sciences 79:1.
Crossref
Crossref
David S. KrollDavid S. Kroll. 2022. Caring for Patients with Depression in Primary Care. Caring for Patients with Depression in Primary Care
61
73
.
Erhan Kavakbasi & Bernhard T. Baune. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
4033
4073
.
Michel Bourin. 2022. Translational Research Methods for Major Depressive Disorder. Translational Research Methods for Major Depressive Disorder
57
84
.
Ivan Emmanuel Ramos-Martínez, María Carmen Rodríguez, Marco Cerbón, Juan Carlos Ramos-Martínez & Edgar Gustavo Ramos-Martínez. (2021) Role of the Cholinergic Anti-Inflammatory Reflex in Central Nervous System Diseases. International Journal of Molecular Sciences 22:24, pages 13427.
Crossref
Crossref
Fangyue Chen, Emad Sidhom, Sharon Yang, Eladia Ruiz-Mendoza & Julius Essem. (2021) Case report: delayed response after electroconvulsive therapy in a patient with major depressive disorder. BMC Psychiatry 21:1.
Crossref
Crossref
Víctor Pérez-Sola, Miquel Roca, Jordi Alonso, Andrea Gabilondo, Teresa Hernando, Antoni Sicras-Mainar, Aram Sicras-Navarro, Berta Herrera & Eduard Vieta. (2021) Economic impact of treatment-resistant depression: A retrospective observational study. Journal of Affective Disorders 295, pages 578-586.
Crossref
Crossref
Bernhard T. Baune, Emma Sampson, Jennie Louise, Hikaru Hori, K. Oliver Schubert, Scott R. Clark, Natalie T. Mills & Célia Fourrier. (2021) No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial. European Neuropsychopharmacology 53, pages 34-46.
Crossref
Crossref
Naghmeh Nikkheslat. (2021) Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency. Brain, Behavior, & Immunity - Health 18, pages 100383.
Crossref
Crossref
Grigorios N. Karakatsoulis, Eva-Maria Tsapakis, Calypso Mitkani & Konstantinos N. Fountoulakis. (2021) Subclinical thyroid dysfunction and major depressive disorder. Hormones 20:4, pages 613-621.
Crossref
Crossref
Dong-Bin Cai, Hua-Rong Zhou, Wan-Nian Liang, Li-Mei Gu, Mei He, Xiong Huang, Zhan-Ming Shi, Hua-Cheng Hou & Wei Zheng. (2021) Adjunctive Nonconvulsive Electrotherapy for Patients with Depression: a Systematic Review. Psychiatric Quarterly 92:4, pages 1645-1656.
Crossref
Crossref
Giulio Perugi, Paola Calò, Sergio De Filippis, Gianluca Rosso, Antonio Vita, Marina Adami, Giuseppe Ascione, Joachim Morrens & Dario Delmonte. (2021) Clinical Features and Outcomes of 124 Italian Patients With Treatment Resistant Depression: A Real-World, Prospective Study. Frontiers in Psychiatry 12.
Crossref
Crossref
Stefano Pallanti, Anna Marras, Suzanne L Dickson, Roger AH Adan, Eduard Vieta, Bernardo Dell Osso, Celso Arango, Paolo Fusar-Poli, Carles Soriano-Mas, Lior Carmi, Andreas Meyer Lindenberg & Joseph Zohar. (2021) Manifesto for an ECNP Neuromodulation Thematic Working Group (TWG): Non-invasive brain stimulation as a new Super-subspecialty. European Neuropsychopharmacology 52, pages 72-83.
Crossref
Crossref
Timo T. Myöhänen, Freke Mertens, Susanna Norrbacka & Hengjing Cui. (2021) Deletion or inhibition of prolyl oligopeptidase blocks lithium‐induced phosphorylation of GSK3b and Akt by activation of protein phosphatase 2A. Basic & Clinical Pharmacology & Toxicology 129:4, pages 287-296.
Crossref
Crossref
Luca Sforzini. (2021) Lost in translation. The quest for definitions of treatment-resistant depression with a focus on inflammation-related gene expression. Brain, Behavior, & Immunity - Health 16, pages 100331.
Crossref
Crossref
Maryia Zhdanava, Swapna Karkare, Dominic Pilon, Kruti Joshi, Carmine Rossi, Laura Morrison, John Sheehan, Patrick Lefebvre, Oliver Lopena & Leslie Citrome. (2021) Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug–Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression. Advances in Therapy 38:9, pages 4900-4916.
Crossref
Crossref
Alisha Sapkota, Hajra Khurshid, Israa A Qureshi, Nasrin Jahan, Terry R Went, Waleed Sultan & Michael Alfonso. (2021) Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression in Adults: A Systematic Review. Cureus.
Crossref
Crossref
Miguel A. Alvarez-Mon, Miguel A. Ortega, Cielo García-Montero, Oscar Fraile-Martinez, Jorge Monserrat, Guillermo Lahera, Fernando Mora, Alberto Rodriguez-Quiroga, Sonia Fernandez-Rojo, Javier Quintero & Melchor Alvarez-Mon. (2021) Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects. Pharmaceuticals 14:8, pages 821.
Crossref
Crossref
Xue Gong, Cheng Huang, Xun Yang, Jianjun Chen, Juncai Pu, Yong He & Peng Xie. (2021) Altered Fecal Metabolites and Colonic Glycerophospholipids Were Associated With Abnormal Composition of Gut Microbiota in a Depression Model of Mice. Frontiers in Neuroscience 15.
Crossref
Crossref
Tom Denee, Cicely Kerr, Timothy Ming, Robert Wood, Theo Tritton, Chloe Middleton-Dalby, Olivia Massey & Mitesh Desai. (2021) Current treatments used in clinical practice for major depressive disorder and treatment resistant depression in England: A retrospective database study. Journal of Psychiatric Research 139, pages 172-178.
Crossref
Crossref
K. Heerlein, G. Perugi, C. Otte, T. Frodl, G. Degraeve, W. Hagedoorn, A.J. Oliveira-Maia, V. Perez Sola, S. Rathod, G. Rosso, P. Sierra, S. Malynn, J. Morrens, C. Verrijcken, B. Gonzalez & A.H. Young. (2021) Real-world evidence from a European cohort study of patients with treatment resistant depression: Treatment patterns and clinical outcomes. Journal of Affective Disorders 290, pages 334-344.
Crossref
Crossref
Umberto Albert, Pallavi Lamba & Stephen M. Stahl. (2021) Early response to trazodone once-a-day in major depressive disorder: review of the clinical data and putative mechanism for faster onset of action. CNS Spectrums 26:3, pages 232-242.
Crossref
Crossref
Robert M. McCarron, Bryan Shapiro, Jody Rawles & John Luo. (2021) Depression. Annals of Internal Medicine 174:5, pages ITC65-ITC80.
Crossref
Crossref
Aristotle N. Voineskos, Daniel M. Blumberger, Christin Schifani, Colin Hawco, Erin W. Dickie, Tarek K. Rajji, Benoit H. Mulsant, George Foussias, Wei Wang & Zafiris J. Daskalakis. (2021) Effects of Repetitive Transcranial Magnetic Stimulation on Working Memory Performance and Brain Structure in People With Schizophrenia Spectrum Disorders: A Double-Blind, Randomized, Sham-Controlled Trial. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 6:4, pages 449-458.
Crossref
Crossref
Rashmi Patel, Jessica Irving, Aimee Brinn, Matthew Broadbent, Hitesh Shetty, Megan Pritchard, Johnny Downs, Robert Stewart, Robert Harland & Philip McGuire. (2021) Impact of the COVID-19 pandemic on remote mental healthcare and prescribing in psychiatry: an electronic health record study. BMJ Open 11:3, pages e046365.
Crossref
Crossref
Wei Zheng, Miao-Ling Jiang, Hong-Bo He, Ri-Peng Li, Qi-Long Li, Chun-Ping Zhang, Su-Miao Zhou, Su Yan, Yu-Ping Ning & Xiong Huang. (2020) A Preliminary Study of Adjunctive Nonconvulsive Electrotherapy for Treatment-Refractory Depression. Psychiatric Quarterly 92:1, pages 311-320.
Crossref
Crossref
Adele Framer. (2021) What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications. Therapeutic Advances in Psychopharmacology 11, pages 204512532199127.
Crossref
Crossref
Chiara Fabbri, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Diego Albani, Gianluigi Forloni, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Diana De Ronchi, Marco Andrea Riva, Cathryn M. Lewis & Alessandro Serretti. (2021) Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 104, pages 110050.
Crossref
Crossref
Luann Richardson & Anand Brahmbhatt. (2021) Depression in Primary Care. The Journal for Nurse Practitioners 17:1, pages 37-43.
Crossref
Crossref
Martin Schecklmann, Vahid Nejati, Timm B. Poeppl, Juliette Peytard, Rainer Rupprecht, Thomas C. Wetter, Berthold Langguth & Peter M. Kreuzer. (2021) Bifrontal high-frequency transcranial random noise stimulation is not effective as an add-on treatment in depression. Journal of Psychiatric Research 132, pages 116-122.
Crossref
Crossref
Erhan Kavakbasi & Bernhard T. Baune. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
41
.
Victor Distefano Wiltenburg, Dianne da Rocha Prado & Fúlvio Rieli Mendes. 2021. Drugs and Human Behavior. Drugs and Human Behavior
479
510
.
Jakub Słupski, Wiesław Jerzy Cubała, Natalia Górska, Anita Słupska & Maria Gałuszko-Węgielnik. (2020) Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression. Brain Sciences 10:12, pages 971.
Crossref
Crossref
Eva Češková & Petr Šilhán. (2020) Treatment options for pharmacoresistant depression in routine clinical practice. Psychiatrie pro praxi 21:3, pages 124-127.
Crossref
Crossref
Maud Tastevin, Laurent Boyer, Theo Korchia, Guillaume Fond, Christophe Lançon, Raphaëlle Richieri & Eric Guedj. (2020) Brain SPECT perfusion and PET metabolism as discordant biomarkers in major depressive disorder. EJNMMI Research 10:1.
Crossref
Crossref
Pichit Buspavanich, Cornelia König & Mazda Adli. (2020) Rezidivprophylaxe der Depression: Pharmakologie. PSYCH up2date 14:06, pages 487-498.
Crossref
Crossref
Elisabeth B. Binder. (2020) Understanding the mechanisms of treatment response in depression, focus on electro-convulsive therapy. European Archives of Psychiatry and Clinical Neuroscience 270:7, pages 789-791.
Crossref
Crossref
Olaitan J. Jeremiah, Gráinne Cousins, Fiona Boland, Brian P. Kirby & Benedict K. Ryan. (2020) Evaluation of the effect of insulin sensitivity-enhancing lifestyle- and dietary-related adjuncts on antidepressant treatment response: A systematic review and meta-analysis. Heliyon 6:9, pages e04845.
Crossref
Crossref
Brenda Moreira dos Santos, Gabriele Cheiran Pereira, Elisa Piton, Maria Fernanda Pessano Fialho, Gabriela Becker, Marieli da Silva Carlotto, Sara Marchesan Oliveira, Gabriela Trevisan, Eliane Maria Zanchet, Micheli Mainardi Pillat & Guilherme Vargas Bochi. (2021) Lower Antidepressant Response to Fluoxetine Is Associated With Anxiety-Like Behavior, Hippocampal Oxidative Imbalance, and Increase on Peripheral IL-17 and IFN-γ Levels. SSRN Electronic Journal.
Crossref
Crossref